opioid drugs in patients with liver disease: a systematic review
Authors
abstract
conclusions pain management in patients with liver dysfunction is always challenging to physicians because of the adverse reactions of drugs, especially opioids. opioids should be used cautiously since they can cause sedation, constipation and sudden encephalopathy effects. since the clearance of these drugs in patients with hepatic insufficiency is decreased, the initial dose must be decreased, the intervals between doses should be increased and some patients need to be continuously assessed. results in patients with liver disease, administration of opioid analgesics should be observed, accurately. as a general rule, lower doses of drugs should be administered at regular intervals based on the signs of drug accumulation. secondly, the interactions of opioid drugs with different levels of substrates of the p450 cytochrome enzyme should be considered. context the liver, one of the most important organs of the body, is known to be responsible for several functions. the functional contribution of the liver to the metabolism of carbohydrates, protein, drugs and toxins, fats and cholesterol and many other biological processes are still unknown. liver disorders are classified into two types: acute and chronic. different drugs are used in liver diseases to treat and control pain. most pain relief medications such as opioids are metabolized via the liver; therefore, the adverse reactions of drugs are probably higher for patients with liver disease. the current study aimed to evaluate the effects of opioid drugs on patients with liver disease; therefore, it is necessary to select suitable opioids for such patients. evidence acquisition this review was written by referring to research literature including 70 articles and four textbooks published from 1958 to 2015 on various reputable sites. searches were carried out on the key phrases of narcotic pain relievers (opioids), acute and chronic hepatic failure, opioid adverse drug reactions, drug-induced liver injury (dili) and other similar keywords. references included a variety of research papers (descriptive and analytical), intervention and review articles.
similar resources
Opioid Drugs in Patients With Liver Disease: A Systematic Review
CONTEXT The liver, one of the most important organs of the body, is known to be responsible for several functions. The functional contribution of the liver to the metabolism of carbohydrates, protein, drugs and toxins, fats and cholesterol and many other biological processes are still unknown. Liver disorders are classified into two types: acute and chronic. Different drugs are used in liver di...
full textThe Effect of Proposed Drugs in the Treatment of Patients with COVID- 19: A Systematic Review
Background: No proven effective treatment for coronavirus disease (COVID-19) currently exist. Different drugs have different effects on patients with Covid-19, and the potential benefits or harms of the proposed drugs for the treatment of this disease need to be discussed more fully. The aim of this study was to systematically review the effectiveness of the proposed drugs in the treatment of p...
full textQuality of Life in Patients With Liver Cirrhosis: A Systematic Review
Background: Quality of life (QOL) is a powerful phrase that reflects maintaining health and well-being in different societies and cultures, reflecting the positive and negative aspects of people’s lives. Patients with liver cirrhosis (LC) have an undesirable QOL, and this has become one of the most important causes of mortality in the world. Objective: Th...
full textP181: Effect of Aquatic Therapy on Improvement of Patients with Parkinson Disease: A Systematic Review
Parkinson disease (PD) is a degenerative neurological disorder that affects 0.5- 1% of old people in western countries. It primarily affects mobility function, and associated with increasing disability over time. People with PD express bradykinesia, rigidity, tremor, progressive postural instability and muscle weakness as symptoms of PD. Various exercise programs, including resistance or aerobi...
full textEvaluation of the effects of resveratrol on non-alcoholic fatty liver disease A systematic review study
Introduction: Non-alcoholic fatty liver disease (NAFLD) is a condition in which triglycerides accumulate in liver cells without a history of alcohol consumption. Evidence has shown that auxiliary treatments, including the use of antioxidant compounds, can be effective in improving nonalcoholic fatty liver. Resveratrol is an antioxidant compound that has been shown to be beneficial in some disea...
full textMy Resources
Save resource for easier access later
Journal title:
hepatitis monthlyجلد ۱۶، شماره ۴، صفحات ۰-۰
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023